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Abstract. Background: Melasma and lentigo solaris are common, recurrent, and refractory 
acquired hyperpigmentation disorder. Azelaic acid (AA) is a depigmenting agent acts by 
inhibition of DNA synthesis and mitochondrial enzymes, thereby inducing direct cytotoxic 
effects on melanocytes. Glycolic acid (GA) peels alone or in combination with topical 
hypopigmenting agents has shown encouraging results. However, there is paucity of 
controlled trial demonstrating the efficacy of GA peels in conjunction with topical AA. Case: 
A 42-years-old female, a street vendor, had dark brown spots on both cheeks, nose, chin and 
forehead that spreads to whole face since one year ago. She had a history of using 
contraceptives. There were multiple well-circumscribed, irregular hyperpigmented macules 
that asymmetrical, with size ranging from lenticular to plaque on the maxillary, left buccalis, 
mentalis and frontalis region. We also found a numular dark brown hyperpigmented macules 
on right zygoma. She was diagnosed with melasma and lentigo solaris. The Melasma Area 
Severity Index (MASI) score was 25.6, which classified as moderate melasma. She was 
treated with 20% azaleic acid cream twice a day, broadspectrum sunscreen with SPF 50 and 
GA 20% peeling. Result: After 6 weeks of treatment, there were significant  improvement 
in both melasma and lentigo solaris. 
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1 Introduction 
Melasma and lentigo solaris are common, recurrent, and refractory acquired hyperpigmentary 
disorder [1,2]. Study of Jusuf conducted in Cosmetic Dermatology Clinic H. Adam Malik General 
Hospital Medan from 2012-2015, the largest proportion of pigmentation disorder was 
hypermelanosis, with melasma as the most common diagnosis [3]. In spite of variety of 
therapeutic options available for this cosmetically disfiguring condition, their treatment is really 
challenging. Currently available treatment modalities include topical agents such as 
hydroquinone, azelaic acid (AA), kojic acid, retinoic acids, and their various combinations; and 
chemical peels such as glycolic acid (GA), lactic acid, trichloroacetic acid, phenol, and Laser. 
Unfortunately, the results of monotherapies are usually disappointing, especially in dark-skinned 
individuals [1,2]. 
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Azelaic acid (AA) is a depigmenting agent which acts by inhibition of DNA synthesis and 
mitochondrial enzymes, thereby inducing direct cytotoxic effects on melanocytes. Moreover, it 
acts selectively on hyperactive and abnormal melanocytes; thus, neither leukoderma nor 
exogenous ochronosis is associated with its use [4]. Glycolic acid (GA) peel act in 
hyperpigmentation due to the effect on epidermal remodeling, accelerated desquamation, and its 
additive inhibitory effect on melanin synthesis, resulting in quick pigment dispersion. GA peel is 
considered to be the most versatile peeling agent as it has good penetration because of its low 
molecular weight, increased bioavailability, easily neutralized, and being superficial, and it has 
very few postpeel complications [5,6].  
Recently, some studies have combined GA peel with various topical hypopigmenting agents such 
as hydroquinone 4% [7], azelaic acid 20% plus adapalene gel 0.1%,2 and modified Kligman’s 
formula to enhance the efficacy of treatment and have found to produce better results. As there is 
paucity of studies demonstrating the efficacy and safety of combining GA peel and 20% AA 
cream in treatment of epidermal melasma, this treatment was undertaken. 
2 Case 
A 42 years old female, married,  work as a street vendor came to our clinic on 12 December 2017 
with dark brown spots without pain and itching on both cheeks, nose, chin and forehead which 
started a years ago and spread to whole face within one year. Initially, light brown spots appeared 
on both cheeks then extended to the nose, chin and forehead with darker color. Patients had never 
use sunscreen or protective hats when they were outdoors. She also had never used drugs to get 
rid of this complaint. She had history of using injectable contraception for 10 years and replaced 
with oral contraceptives for 4 years, but within 3 months the patient had stopped using 
contraception. Family history of suffering from the same thing was denied by the patient. 
Dermatological examination showed multiple well-circumscribed, irregular hyperpigmented 
macules that asymmetrical, with size ranging from lenticular to plaque on the maxillary, left 
buccalis, mentalis and frontalis region. We also found a numular dark brown hyperpigmented 
macules on right zygoma.  (Figure 1). The differential diagnosis of the patient were melasma + 
lentigo solaris, exogenous ochronosis + actinic keratosis, and efelid + seborrheic keratosis,. The 
patient was diagnosed with melasma + lentigo solaris. 
The assessment based on the MASI score for these patients when she first arrived was: 
MASI  = 0.3 (DF+HF)AF + 0.3 (DMR+HMR)AMR + 0.3 (DML+HML)AML + 0.1 (DC+HC)AC 
 = 0.3 (1+1)2 + 0.3 (4+4)5 + 0.3 (4+4)5 + 0.1 (1+1)2 
 = 25.6 (moderate melasma) 
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Figure 1 First visit: multiple well-circumscribed, irregular hyperpigmented macules that 
asymmetrical, with size ranging from lenticular to plaque maxillary region, frontal and 
nasal regions. There are also numular size hyperpigmented macules to multiple plaques, 
discrete in the right zygoma region. 
Patient was treated with 20% azaleic acid cream which applied in the morning and night, also 
SPF 50 sunscreen cream which applied to 15 minutes before exposure to sunlight. In addition, 
patients are also recommended to avoid direct exposure to sunlight by wearing a protective 
umbrella such as an umbrella or hat when outdoors. Patients were also recommended for control 
2 weeks later for chemical peels with 20% GA, with discontinuation of the azaleic acid cream 3 
days before. 
The patient came after 3 weeks of treatment, there was little significant improvement on multiple 
hyperpigmented macules on maxillary region, frontal and nasal regions also on numular sized 
hyperpigmentation macule on the zygoma region (Figure 2). Assessment of MASI score was 0 + 
9.6 + 9.6 + 0.1 = 19.3 which classified as mild melasma. Chemical peel with 20% AG solution 
was performed. The other treatment of patient was still continue as before. Patient was asked to 
control again 3 weeks later for repetition of chemical peels. 
After 6 weeks of treatment, there were all improvement on hyperpigmented macules on maxillary 
region, frontal and nasal regions, also numular sized hyperpigmentation macule on the zygoma 
region (Figure 3). MASI score assessment was 0 + 2,4 + 2,4 + 0,1 = 4,9 which classified no 
melasma. The therapy was still continue with azaleic acid cream as maintenance therapy. 
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Figure 2 After 3 weeks of treatment: A slightly faded, well-circumscribed multiple 
hyperpigmented macules with irregular, asymmetrical edges, numular size to plaque, on 
maxillary region, frontal and nasal regions. There was still no improvement on numular 
sized hyperpigmentation macule on the zygoma region. 
 
 
 
 
 
 
 
Figure 3 After 6 weeks of treatment: There were overall improvement on multiple 
hyperpigmented macules on the maxillary region and frontal and buccal region. The 
numular sized hyperpigmentation macule on right zygoma is also faded.  
3 Discussion 
Therapeutic modalities for melasma and lentigo solaris are similar. Chemical peeling is the most 
innovative weapon in the therapeutic armamentarium for melasma and also lentigo solaris. The 
benefits of alpha hydroxy acids as peeling agents have long been recognized, of which glycolic 
acid is the commonest peeling agent. However, even with the higher concentration of GA peel, 
that is, 50%, an average improvement in terms of MASI score of only 46.7% has been observed 
in epidermal melasma [5]. Thus, with the aim of improving the degree of response to therapy, 
many workers have used GA peeling in conjunction with various topical hypopigmenting 
agents[2.7]. Azelaic acid is a safe and effective hypopigmenting agent in melasma especially in 
epidermal variety. So it would be interesting to combine GA peels with topical AA for enhancing 
the improvement in melasma, thereby improving the health related quality of life and patient’s 
satisfaction [4,7]. 
The patient’s job as a street vendor causes longer sun exposure and she had also a history of using 
oral and injected contraceptives which accordance with the risk factors for melasma are 
environmental and endocrine factors [8-11]. Prolonged UV exposure-induced dermal 
inflammation and fibroblast activation may upregulate stem cell factors in the melasma dermis, 
causing increased melanogenesis [8-10]. Mahdalena et al found 20,5% melasma among hormonal 
contraceptive acceptors which is oral contraceptive pils is the highest proporsion followed by 
injection and implant [11]. Various studies showed evidence of hormonal involvement in the 
genesis of the disease, since high levels of estrogen, progesterone and melanocortin are possible 
triggering factors of melasma during pregnancy. Estrogen increases vascularization of the skin, 
suppresses the activity of sebaceous glands and also increases pigment cell activities. 
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Progesterone increase the spread of melanin in cells and the expression of PR proteins in skin 
hyperpigmentation due to melasma [9-11]. 
However, clinical experience of combination of GA peel with azelaic acid in melasma is very 
limited [12]. Azelaic acid is a depigmenting agent which acts by inhibition of DNA synthesis and 
mitochondrial enzymes, thereby inducing direct cytotoxic effects on melanocytes. Moreover, it 
acts selectively on hyperactive and abnormal melanocytes; thus, neither leukoderma nor 
exogenous ochronosis is associated with its use [4]. GA peel act in melasma due to the effect on 
epidermal remodeling, accelerated desquamation, and its additive inhibitory effect on melanin 
synthesis, resulting in quick pigment dispersion. GA peel is considered to be the most versatile 
peeling agent as it has good penetration because of its low molecular weight, increased 
bioavailability, easily neutralized, and being superficial, and it has very few postpeel 
complications [5,6].  
The improvement in MASI scoring were significant in 6 weeks of treatment without any side 
effect. This reflects higher efficacy of the combination therapy as compared to the topical AA 
cream alone. Based on the findings of Erbil et al who had also shown a statistically significant 
decrease in mean MASI and percentage decrease in MASI in the combination group as compared 
to control group at completion of the study. In the Erbil et al study, the percentage decrease in 
MASI after completion of treatment was higher (83.8%) as compared to study group (58.72%). 
This might be due to the reason that in our case, we used only AA cream with serial GA peel, 
while in Erbil et al.’s study, they have used AA cream with 0.1% adapalene gel in combination 
with serial GA peel [2]. Thus, the use of additional topical agent, that is, adapalene 0.1% gel 
which acts in lightening of melasma by accelerating skin turnover and enhancing the efficacy of 
bleaching agents, may be responsible not only for higher percentage decrease in MASI score but 
also in side effects like erythema, pruritus, and post inflammatory hyperpigmentation (PIH) 
[7,12]. 
4 Conclusion 
The combination of topical AA cream and 20% GA peels are well-tolerated and highly effective 
strategy in melasma and lentigo solaris, thereby leading to improved patient’s compliance. 
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